The latest reminder of Big Pharma’s influence over the American healthcare sector did not come from a footnote in a medical journal, but from Washington trade policy. In July 2026, POLITICO reported pharmaceutical companies were aggressively lobbying US trade officials to open tariff investigations into European countries with tightly controlled medicine prices. The strategy was not simply to tax medicines at the border.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ure
Contact Ure, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack